3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
16
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
8
Sarcoma
1
Peripheral Nervous System Diseases
1
Neoplasm Metastasis
1
Breast Cancer Organoids
1
Interventions
Gene Expression Profiling
9
Surveys and Questionnaires
7
Blood Specimen Collection
7
Surgical Procedures, Operative
6
Polymerase Chain Reaction
6
Microarray Analysis
4
Immunohistochemistry
4
Base Sequence
4
Trabectedin
3
Therapeutics
3
Reverse Transcriptase Polymerase Chain Reaction
3
Radiation
3
Psychiatric Rehabilitation
3
Observation
3
Drug Therapy
3
Radiotherapy
2
Patient Reported Outcome Measures
2
Molecular Diagnostic Techniques
2
Methods
2
In Situ Hybridization, Fluorescence
2
Gene Rearrangement
2
DNA Methylation
2
Amplified Fragment Length Polymorphism Analysis
2
trastuzumab deruxtecan
1
pazopanib
1
liposomal doxorubicin
1
fluorodopa F 18
1
eribulin
1
Watchful Waiting
1
Urine Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Sarcoma
×
eribulin
×
Clear all
NCT03058406
2020-04-06
HAL03T
Eisai Inc.
Completed
256 enrolled